Scholarly Index
Alan R. Shuldiner
Regeneron (United States); 87,921 total citations; 666 total publications; best world rank #141
Regeneron (United States)
87,921Total citations
666Total publications
128H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Adipose Tissue and Metabolism | Lifetime | 280 | US 138 | 99.24 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 141 | US 63 | 99.25 |
| Metabolism, Diabetes, and Cancer | Lifetime | 335 | US 154 | 98.67 |
| Pancreatic function and diabetes | Lifetime | 541 | US 239 | 98.45 |
| Peroxisome Proliferator-Activated Receptors | Lifetime | 349 | US 175 | 97.56 |
| Genetic Associations and Epidemiology | Lifetime | 423 | US 201 | 97.80 |
| Diabetes Treatment and Management | Lifetime | 724 | US 268 | 97.48 |
| Diabetes and associated disorders | Lifetime | 794 | US 308 | 97.28 |
| Lipoproteins and Cardiovascular Health | Lifetime | 622 | US 289 | 97.52 |
| Molecular Biology Techniques and Applications | Lifetime | 593 | US 293 | 96.01 |
| Agriculture and Farm Safety | Lifetime | 803 | US 348 | 83.86 |
| Genetic Associations and Epidemiology | 2021-2025 | 864 | US 366 | 87.01 |
| Agriculture and Farm Safety | 2021-2025 | 985 | US 379 | 16.75 |